LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
|
|
|
- Jack Payne
- 6 years ago
- Views:
Transcription
1 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM. A. COLPOSCOPY: DONE... T DONE... (Ad) PARTICIPANT REFUSED...3 (END) Aa. DATE OF PROCEDURE: / / M D Y Ab. COLPOSCOPY PERFORMED BY: (ENTER INITIALS OF COLPOSCOPIST/S) i ii Ac. WAS COLPOSCOPY PERFORMED BY A WIHS COLPOSCOPIST?... (A)... (PROMPT) PROMPT: IF QUESTION Ac = (I.E., COLPOSCOPY WAS PERFORMED BY A N-WIHS COLPOSCOPIST), THEN COMPLETE ACSR ATC FORM AND PROCEED TO QUESTION A. WIHS Laboratory Form L4: Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4
2 Ad. REASON COLPO T DONE: PROMPT: Unable to contact participant (e.g., no phone, homeless, no response to attempts)... Participant was no show for multiple appointments... Participant was too ill to be scheduled at this time... 3 Participant s work/school schedule prevented her from coming... 4 Participant moved out of area / too difficult to travel... 5 Participant is incarcerated... 6 Staff unable to obtain colpo results from primary care OB/GYN for L4 completion... 7 Other... 8 END FORM AFTER COMPLETING QUESTION Ad. A. INDICATION FOR COLPOSCOPY (CIRCLE OR FOR EACH OF THE FOLLOWING I a. Prior history of Dysplasia... b. ASCUS, AGUS, Koilocytosis or SIL on recent WIHS Pap Smear... c. Presence of visible cervical or vaginal lesions... d. Presence of visible vulvar or perianal lesions... e. Post coital bleeding when not menstruating... f. Positive HPV detection test... g. Research only... h. Other... WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4
3 A3. TYPE OF COLPOSCOPY PERFORMED: a. Cervical b. Vaginal c. Vulvar d. Perianal e. Anal (anoscopy) A4. WAS CERVIX PRESENT? COLPOSCOPY RESULTS: A5. CERVICAL EXAM ADEQUACY: (SKIP TO A0) SATISFACTORY... ENDOCERVICAL SPECULUM USED TO VISUALIZE SQUAMOCOLUMNAR JUNCTION... SQUAMOCOLUMNAR JUNCTION T VISUALIZED... 3 A6. GENERAL CATEGORIZATION OF CERVICAL COLPOSCOPY: WITHIN RMAL LIMITS... (A0) ABRMAL FINDINGS... A7. ABRMAL COLPOSCOPIC FINDINGS FOUND T FOUND a. Keratosis (leukoplakia) b. Aceto-White Epithelium c. Punctation d. Mosaicism e. Atypical Vessels f. Other WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 3 of 4
4 A8. WHAT PERCENT (%) OF TRANSFORMATION ZONE WAS ABRMAL? 0%... < 5%... 5% - < 50% % - < 75% % - 00%...5 A9. What quadrants are abnormal? a. Endocervix (#8)... b. Inner upper left quadrant (#9) c. Inner lower left quadrant (#0)... d. Inner lower right quadrant (#) e. Inner upper right quadrant (#)... f. Outer upper left quadrant (#3)... g. Outer lower left quadrant (#4) h. Outer lower right quadrant (#5)... i. Outer upper right quadrant (#6)... OTHER FINDINGS FOUND T FOUND LOCATION IF FOUND A0. Inflammation (A) a. Vaginal b. Cervical c. Vulvar d. Perianal e. Anal A. Polyp/Papilloma (A) a. Vaginal b. Cervical c. Vulvar d. Perianal e. Anal A. Condyloma acuminatum (A3) a. Vaginal b. Cervical c. Vulvar d. Perianal e. Anal WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 4 of 4
5 OTHER FINDINGS FOUND T FOUND LOCATION IF FOUND A3. Other: a. (A5) b. Vaginal c. Cervical d. Vulvar e. Perianal f. Anal A4. Other: a. (A5) b. Vaginal c. Cervical d. Vulvar e. Perianal f. Anal A5. WAS PAP SMEAR PERFORMED WITH THIS COLPOSCOPY? A6. CERVICAL BIOPSY TAKEN? a. ECC Performed (SKIP TO A7) DELAYED...3 (SKIP TO A7) REFUSED... <-7> (SKIP TO A7) DELAYED...3 REFUSED... <-7> b. Colposcopically Directed Punch Biopsy... (c) i) Number of punch biopsies taken: ii) Location(s) taken: (round to nearest o'clock) a. o'clock b. o'clock c. o'clock d. o'clock WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 5 of 4
6 c. Cervical Excisional Biopsy (other than punch biopsy)... (d) i) Location taken: o'clock to o'clock d. Loop Excision of Transformation Zone (LLETZ, LETZ, LEEP)... (e) i. ectocervical passes...(a) a. enter # of passes e. Cervical Cone Biopsy... (A7) (CIRCLE ONE TYPE) Laser... (A7) Cold Knife... (A7) Loop... 3 i. ectocervical passes (a) (ii) a. enter # of passes ii. endocervical core A7. Overall impression of Cervix (Circle the highest grade lesion). RMAL... ABRMAL, BUT SIL... LOW GRADE...3 HIGH GRADE...4 INVASIVE...5 CERVIX T PRESENT...6 (A8) WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 6 of 4
7 a. TOTAL NUMBER OF CERVICAL LESIONS: none... one... two...3 three...4 four...5 five to nine...6 > ten...7 A8. OTHER N-CERVICAL BIOPSIES TAKEN? (SKIP TO A6) DELAYED...3 (SKIP TO A6) REFUSED... <-7> (SKIP TO A6) TYPE BIOPSIES TAKEN ENTER UP TO LOCATION CODES FOR EACH TYPE A9. Vaginal... (A0) a) b) A0. Vulvar... (A) a) b) A. Perianal... (A) a) b) A. Anal (Anoscopy)*... (A3) a) b) A3. Endometrial... A4. Other... (A6) b) c) a. A5. Other... (A6) b) c) a. LOCATION CODES ARE LOCATED ON PAGES 0- * COMPLETE SECTION B ON PAGES - 4 OF THIS FORM WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 7 of 4
8 A6. a. TOTAL NUMBER OF VAGINAL LESIONS: none... one... two...3 three...4 four...5 five to nine...6 > ten...7 b. TOTAL NUMBER OF VULVAR LESIONS: none... one... two...3 three...4 four...5 five to nine...6 > ten...7 c. TOTAL NUMBER OF PERIANAL LESIONS: A7. MAXIMUM LESION SIZE: IF LESION PRESENT, CODE AS - none... one... two...3 three...4 four...5 five to nine...6 > ten...7 a. vaginal. cm b. vulvar. cm c. perianal. cm d. anal. cm e. Other. cm (SPECIFY LOCATION) A8. TOTAL NUMBER OF BIOPSIES TAKEN (Include both cervical and non-cervical): a. TOTAL NUMBER OF BIOPSIES DELAYED OR REFUSED (Include both cervical and non-cervical): WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 8 of 4
9 A9. OVERALL IMPRESSION: (CIRCLE THE HIGHEST N-CERVICAL GRADE LESION) RMAL...(A33) ABRMAL, BUT SIL... LOW GRADE...3 HIGH GRADE...4 INVASIVE...5 A30. LOCATION OF THE HIGHEST GRADE N-CERVICAL LESION: a) Vagina... b) Vulva... c) Perianal... d) Anal... e) Other... WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 9 of 4
10 A3. CIRCLE THE NUMBERS FOR THE LESION LOCATIONS: LOCATION CODES. Labium Majus (left) 7. Perianus upper left. Labium Majus (right) 8. Perianus lower left 3. Labium Minus (left) 9. Perianus lower right 4. Labium Minus (right) 30. Perianus upper right 5. Introitus (left) 3. Internal Anus 6. Introitus (right) 7. Perineum (left) 8. Perineum (right) 9. Inguinal (left) 0. Inguinal (right). Thigh (left) Thigh (right) 3. Clitoris 4. Urethra 5. Pubis WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 0 of 4
11 A3. CIRCLE THE NUMBERS FOR LESION LOCATIONS: LOCATION CODES. Anterior vaginal wall, proximal third.. Anterior vaginal wall, medial third 3. Anterior vaginal wall, distal third 4. Left lateral vaginal wall, proximal third 5. Left lateral vaginal wall, medial third 6. Left Lateral vaginal wall, distal third 7. Posterior vaginal wall, proximal third 8. Posterior vaginal wall, medial third 9. Posterior vaginal wall, distal third 0. Right lateral vaginal wall, proximal third. Right lateral vaginal wall, medial third. Right lateral vaginal wall, distal third 3 ANTERIOR R.L L.L. INTROITUS FORNIX POSTERIOR VAGINA AND CERVIX (DRAW OS) WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4
12 A33. DID YOU KW THE HIV STATUS AT THE TIME OF THIS EXAM? A34. WAS FOLLOW-UP VISIT SCHEDULED FOR BIOPSY? a) SPECIFY WHERE SCHEDULED: (M.D. OR INSTITUTION) (ADDRESS) SECTION B. ANAL COLPOSCOPY B. ANAL COLPOSCOPY: DONE... T DONE... (END) PARTICIPANT REFUSED... 3 (END) Ba. DATE OF ANAL COLPOSCOPY: / / M D Y Bb. COLPOSCOPY PERFORMED BY: (ENTER INITIALS OF COLPOSCOPIST/S) i ii WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page of 4
13 B. INDICATION FOR ANAL COLPOSCOPY: a. Prior history of anal dysplasia... B3. ARE LESIONS PRESENT? B4. LESIONS b. Abnormal anal cytology... c. Presence of visible perianal lesions... d. Positive anal HPV detection test... e. Research only... f. Other (B8) FOUND T FOUND a. Keratosis (leukoplakia) b. Aceto-White Epithelium c. Punctation d. Mosaicism e. Atypical Vessels f. Condyloma g. Other B5. TOTAL NUMBER OF LESIONS: none... (B8) one... two...3 three...4 four...5 five to nine...6 > ten...7 WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 3 of 4
14 B6. MAXIMUM LESION SIZE: cm B7. LOCATION OF LESION: (REFER TO DEFINITIONS AND DIAGRAM BELOW) B8. WAS A BIOPSY TAKEN? a. Anterior... (b) i. o'clock b. Posterior... (c) i. o'clock c. Anus... d. Crypt/Columnar area... e. Rectum... f. Other (B0) DELAYED... 3 (B0) REFUSED... <-7> (B0) B9. NUMBER OF BIOPSIES TAKEN: B0. ASCOPIC IMPRESSION: (CIRCLE THE HIGHEST N-CERVICAL GRADE LESION) RMAL... ABRMAL, BUT SIL... LOW GRADE...3 HIGH GRADE...4 INVASIVE...5 DEFINITIONS: Posterior Anterior ANUS: (Anal Canal) between Verge and Squamo-Columnar junction (Pectinate Line) CRYPT/COLUMNAR AREA: Between Squamo-Columnar junction and Ano-Rectal (AR) line AR Line Squamo - Columnar Junction A-RECTUM: Between Verge and Ano-Rectal line R L ANUS R L RECTUM: Beyond Ano-Rectal line Verge WIHS Laboratory Form L4 - Pelvic Exam Studies (Colposcopy Results) - 0/0/0a Page 4 of 4
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0 / 0 / 6 ANY MISSING OR INCOMPLETE TEST RESULTS
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 05/01/95 ANY MISSING OR INCOMPLETE TEST RESULTS
Becoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
Introduction to Colposcopy
Introduction to Colposcopy Papanicolaou smear (Pap smear) screening test Colposcopy diagnostic test Introduction to Colposcopy Acetic acid and Lugol s iodine applied Cervix examined under magnification
Cervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
Management that provides continuity of care for women
Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series
HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%
Management Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
WOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8
WOMEN'S INTERAGENCY HIV STUDY GYNECOLOGICAL EXAM FORM 8 AFFIX ID LABEL HERE ---> PARTICIPANT ID: (Enter number here only if ID label is not available) - - - WIHS STUDY VISIT #: FORM VERSION: 04/01/99 EXAMINER'S
Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
Colposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
Cervical Conization. 1
Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
Management of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
CPC on Cervical Pathology
CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade
Conflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives
Advanced Colposcopy Conflict of Interest Disclosure Anita L. Nelson, MD Anita L. Nelson, MD Professor OB-GYN David Geffen School of Medicine at UCLA CFHC s 2014 Women s Health Update Berkeley, CA May 20,
I have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
Twenty-first refresher course. Chan Kit Sheung
Twenty-first refresher course Chan Kit Sheung 7-5-2015 Case 1 Case 1, 29y old, G3P2, referred from MCHC Cervical smear on 27-9-2013: LGSIL, defaulted appointment Cervical smear in 12/2014: negative Colposcopy
Human Papillomavirus (HPV) in Patients with HIV.
Human Papillomavirus (HPV) in Patients with HIV www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS residents with HIV who are screened for HPV-related dysplasia and managed effectively.
GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016
GLANDULAR LESIONS PITFALLS IN MANAGEMENT Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 Introduction Cervical glandular lesions are much less common than squamous lesion Incidence
What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System
What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Manager @ Harris Health System What is a Pap Smear and when is it recommended? Pap smear The Pap smear is a screening
Jean Anderson, MD Catherine Sewell, MD, MPH
Jean Anderson, MD Catherine Sewell, MD, MPH To review diagnosis and management of HPV disease in the setting of HIV infection and address controversies HIV-infected women have: higher prevalence and incidence
SOGC / SCC Clinical Practice Guideline
SOGC / SCC Clinical Practice Guideline Colposcopic Management of Abnormal Cervical Cancer Screening and Histology These Clinical Practice Guidelines have been prepared and approved by the Executive and
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix
,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z
,,,,, PATHOLOGY Q U I Z,,,,, PATHOLOGY QUIZ CASE HISTORY Alex Ferenczy, MD, Professor of Pathology and Obstetries and Gynaecology, The Sir Mortimer B. Davis ]ewish General HosPital, McGill University This
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med
Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK
Colposcopic Principles Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK The cervix topics discussed are: original squamous epithelium endocervical epithelium
Your Colposcopy Visit
Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to
The Case of Mrs. Virginia Jones* Asst. Professor Division of Gyne-Oncology University of British Columbia, Department of Gynecology Vancouver, Canada
Case title: Case authors: Case synopsis: The Case of Mrs. Virginia Jones* Dr. Leslie A. Sadownik Asst. Professor Division of Gyne-Oncology University of British Columbia, Department of Gynecology Vancouver,
Understand Your Results
Understand Your Results The Pap test takes little time and may save your life. This simple screening test checks for cell changes in the cervix, the opening of the uterus. If your Pap results were abnormal,
Cancer in the LGBTQ Community. Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine
+ Cancer in the LGBTQ Community Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine + Objectives Discuss the possible reasons that LGBTQ people have a disproportionate
The society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
High Resolution Anoscopy Overview. Naomi Jay, RN, NP, PhD University of California San Francisco
High Resolution Anoscopy Overview Naomi Jay, RN, NP, PhD University of California San Francisco Email: naomi.jay@ycsf.edy Disclosures No Disclosures Definition of HRA Examination of the anus, anal canal
What Causes Cervical Cancer? Symptoms of Cervical Cancer
Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through
VIN/VAIN O C T O B E R 3 RD J M O R G A N
VIN/VAIN O C T O B E R 3 RD 2 0 1 8 J M O R G A N Vaginal Intraepithelial Neoplasia VAIN I, II, III Incidence 0.1/100,000 women in US Mean age 50s (J Womens Health (Larchmt) 2009:18:1731) (J Obstet Gynaecol
COLPOSCOPY MADE EASY AND SIMPLE
COLPOSCOPY MADE EASY AND SIMPLE Burton Brodsky M.D. Husband, father of four kids Chief of gynecology University of Toledo Assistant residency director University of Toledo Associate professor university
Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY
Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of
I have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
HIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco
Anal cytology and anal cancer in HIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco April 10, 2010 Disclosures Merck and Co: Research grant support, advisory boards
What is cervical cancer?
What is cervical cancer? The cervix is the bottom part, or neck, of the uterus. Cervical cancer happens when normal cells in the cervix change into abnormal cells, and grow out of control. Most women whose
International Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics Treatment of Cervical Precancerous Lesions using Thermocoagulation(Cold Coagulation) and Cryotherapy General Principles All high grade CIN should be
Cervical Cancer 4/27/2016
Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical College of Wisconsin May 6, 2016 Cervical Cancer In US about
Chapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
SESSION J4. What's Next? Managing Abnormal PAPs in 2014
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines
To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy
1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous
Cervical Cancer Early Detection, Diagnosis, and Staging
Cervical Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be
Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
Methods of Obstetrics & Gynecology treatment
Methods of Obstetrics & Gynecology treatment Gynecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus and ovaries) and the breasts Lector: MD Ganna
Estimated New Cancers Cases 2003
Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz Estimated New Cancers Cases 2003 Images removed due to copyright reasons.
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3
Vaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
EFC and European Standards for Colposcopic Evaluation
EFC and European Standards for Colposcopic Evaluation Cagatay Taskiran, MD. Koc University School of Medicine, and VKF American Hospital Department of Obstetrics and Gynecology Division of Gynecologic
Understanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
The Pap Smear Test. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series
The Lebanese Society of Obstetrics and Gynecology Women s health promotion series The Pap Smear Test Since the Pap smear test started to be used the number of cases of cervical cancer was greatly reduced.
Vulvar cancer: Know what to expect
Vulvar cancer: Know what to expect For women with vulvar cancer What is the vulva? The vulva is the external (outside) part of the female genitals. The vulva includes the outer and inner lip, the clitoris,
HPV infections and potential outcomes
CONTENTS Preface by Silvia de Sanjosé... 33 Preface by Jacob Bornstein... 37 Author s note... 39 Acknowledgments... 45 CHAPTER 1 HPV infections and potential outcomes HPV: What it is, where it is and what
Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?
Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this
Cervical Cancer 3/25/2019. Abnormal vaginal bleeding
Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms
Cervical Cancer : Pap smear
Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective
HPV-related papillomatous-condylomatous lesions in female anogenital area
HPV-related papillomatous-condylomatous lesions in female anogenital area Theo Panoskaltsis MD, FRCOG, CCST (UK) Epidemiology Anal cancer is increasing in both men and women Groups at risk: - HIV (+)
Cytology Update M Laing QEUH
Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME
How might we implement screening for anal cancer in HIV-positive patients?
Objective How might we implement screening for anal cancer in HIV-positive patients? Identify the elements required to set up an anal cancer screening and prevention program J. Michael Berry, MD Associate
PREVENTION OF CERVICAL CANCER
PREVENTION OF CERVICAL CANCER Author: Dr R. Fuentes MBchb, Havana Spec. OB,GY-Havana- 2011 CONTENT TABLE Abbreviations 2 Introduction 4 The natural history of Cervical cancer 4 Risk Factors 4 Incidence
Making Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
E-Newsletter. Newsletter of Indian Society of Colposcopy & Cervical Pathology (Reg.)
Volume 3 Issue 3 September - December 2012 Price Rs. 5.00 Indian Society of Colposcopy and Cervical Pathology 2005 (ISCCP) E-Newsletter ISCCP Newsletter of Indian Society of Colposcopy & Cervical Pathology
No Disclosures. Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results. Objectives 5/9/2016
Updated Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical Director, PPWI Medical College of Wisconsin May 6,
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION
Over-diagnoses in Cytopathology: Is histology the gold standard?
Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,
Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.
Cervical Cancer Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. The cervix is the lower, narrow end of the uterus (the hollow, pear-shaped organ where
Managament of Abnormal Cervical Cytology and Histology
Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic
HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists
HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of
Cervical Precancer: Evaluation and Management
TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of
Lauren O Sullivan, D.O. February 19, 2015
Lauren O Sullivan, D.O. February 19, 2015 1. Review basics of Pap smear, cervical dysplasia/cancer and HPV infection. 2. Review 2012 updated screening guidelines. 3. Discuss how and where to find updated
The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy
The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy Introduction Colposcopic impression alone has been shown to be subjective with variable rates
Should Anal Pap Smears Be a Standard of Care in HIV Management?
Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV
HPV, Cervical Dysplasia and Cancer
FACTSHEET HPV, Cervical Dysplasia and Cancer Summary Cervical dysplasia is an abnormal change in the cells of the cervix in the uterus. Early changes, called low-grade lesions by doctors, may persist and
Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital
Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before
1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
CERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS
CERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS A.1. Introduction Women in sub-saharan Africa often present with advanced stages of cervical
Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
A comparative study of two methods of large loop excision of the transformation zone
BJOG: an International Journal of Obstetrics and Gynaecology April 2005, Vol. 112, pp. 490 494 DOI: 10.1111/j.1471-0528.2005.00427.x A comparative study of two methods of large loop excision of the transformation
Cytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
5. Colposcopist performing exam: (Draw SCJ, acetowhite, punctation, mosaics, atypical vessels, and other lesions)
Appendix 1 Colposcopy record 1. Medical Record Number: 2. Patient s Name: EXAMPLE 3. Age: 4. Date of visit: / / (Day/Month/Year) 5. Colposcopist performing exam: 6. Did you see the entire suamocolumnar
Treatment of cervical intraepithelial neoplasia by loop electrosurgical excision procedure (LEEP)
Treatment of cervical intraepithelial neoplasia by loop electrosurgical excision procedure (LEEP) Electrosurgical current applied to tissues can have one of three effects on the tissue, depending on the
BCCCP Approved ICD-9 Code List Fiscal Year 2010
BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant
Investigation of 100 consecutive negative cone biopsies
British Journal of Obstetrics and Gynaecology January 1997, Vol. 104, pp. 100-104 Investigation of 100 consecutive negative cone biopsies *Pouran Golbang Research Fellow and Consultant (Gynaecology), **James
Cervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
HPV and PREGNANCY Arsenio Spinillo,, MD
HPV and PREGNANCY Arsenio Spinillo,, MD University of Pavia, Department of Obstetrics and Gynecology, IRCCS Fondazione Policlinico San Matteo di Pavia Human Papilloma Virus HPV is a member of the Papovaviridae
Information on: Cervical. screening. (smear test) jostrust.org.uk
Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample
Cytyc Corporation - Case Presentation Archive - June 2003
ThinPrep General Cytology History: Asymptomatic 35 Year Old Male Specimen type: Anal Cytology - This specimen was collected using a Dacron swab under proctoscopic visualization. This case was provided
Efficacy of cervical intrarepithelial neoplasia (CIN)
The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,
Information on: Cervical. screening. (smear test) jostrust.org.uk
Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample
Eradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus